Utah Medical Products - Comparative Multiple Analysis

Utah Medical Products (Comparative Multiple Analysis)


Notes on the Comparative Multiple Analysis of Utah Medical Products

WikiWealth compares Utah Medical Products's revenue, EBITDA, and EBIT multiples to their peers in order to determine the appropriate fair valuation. Click in the top right corner to experiment with Utah Medical Products's comparative analysis.

Notes from the analysis:

1. WikiWealth uses quantitative measures to determine the multiple range for Utah Medical Products.
2. Free cash flow to the firm (FCF) multiple is free cash flow to equity holders plus interest owed to Utah Medical Products's debt holders.
3. Multiples incorporate benefits due to economies of scale; WikiWealth compares absolute enterprise value multiples to competitor's multiples.
4. WikiWealth excludes outliers when calculating individual company multiples.

Helpful Information for Utah Medical Products's Analysis

How does this work? The Comparative Investment Analysis determines the value of Utah Medical Products by comparing Utah Medical Products financial ratios, prices, growth rates, margins, etc. to those of relevant peer groups.

Value Investing Importance? This method is widely used by investment professionals to determine the correct price of investments, especially initial public offerings (IPOs). It is one element of WikiWealth's three Wall Street approaches used to determine the correct fair value of Utah Medical Products.

See the Utah Medical Products cash flow (DCF) analysis for a completely different approach that's popular on Wall Street for determining the value of an investment in Utah Medical Products.

Also, see the Utah Medical Products's buffett intrinsic valuation analysis for WikiWealth's attempt to replicate the investing formula's used by Warren Buffett and Utah Medical Products's valuation conclusion for a quick summary.